Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
about
The many ways to make a luminal cell and a prostate cancer cellAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneTbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the ProstateExtracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironmentStromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasiaPrimary xenografts of human prostate tissue as a model to study angiogenesis induced by reactive stromaRepurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiationSonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration.Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics dataGlobal gene expression analysis of reactive stroma in prostate cancer.Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genesmRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.A taxonomy of epithelial human cancer and their metastases.Cancer associated fibroblasts in cancer pathogenesisTGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Mouse models of prostate cancer: picking the best model for the question.Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers.Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcomeOral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype.Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic miceStromal androgen receptor in prostate development and cancer.Perspectives on tissue interactions in development and disease.Modeling stromal-epithelial interactions in disease progression.Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progressionRUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation.Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.Improving prediction of prostate cancer recurrence using chemical imaging.Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblastsHedgehog signaling in prostate epithelial-mesenchymal growth regulation.The functional role of reactive stroma in benign prostatic hyperplasia.The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibitionBiomarker identification with ligand-targeted nucleoprotein assembliesExpression of ERG protein in prostate cancer: variability and biological correlates.
P2860
Q26797386-3AB4D046-6F9B-4B79-A37F-E13E6D0FCD57Q26866067-FAF7B0CA-2E00-4E7F-832E-FDFF0A787C66Q27312119-1FA5CFC0-E13E-470A-9CEA-3178DDEE0B39Q28304032-9475B025-0E64-4E87-88E4-ADE1B882058EQ28533720-B00B848E-FB0A-442F-9A6B-7C90F6F2174FQ28732327-EB976CF0-6D93-4EB0-B2FB-9A1B74476AD8Q28821190-C09B3269-7F29-4054-A839-8DE7797319A8Q30560380-A35C0069-7231-41FA-8C8A-AFCFEFA81D9BQ31070165-03AB664E-3993-42C0-BE2E-DB78D9E146F5Q33464811-3B385866-8004-4B8C-AC89-45931C86D1A5Q33500845-50B49D57-01D0-461B-9699-83F26D532BCAQ33513772-8060549F-92D5-45A5-B305-EE8E061D8880Q33519183-4C2129B0-FB96-4EF1-A772-2206C88CB38AQ33664004-4D59511C-9BA1-4B6E-B534-FDB43DD21219Q33741877-690D76CC-99E5-43BA-BFB5-9621E1E44804Q33761211-9D4D1690-0556-44EF-94C4-F9A092B184BCQ33940867-EB9945EA-0131-4F29-AF2F-A7F673C06B76Q33942225-1D1F1B36-D1CD-4A33-B9C3-38DBCECB4903Q34028208-1AEF969B-28E5-4B27-B003-4B2BEABA4D4FQ34050632-C37F9A19-003E-4DF3-9CA8-4D576232A074Q34300613-0E10B50C-572E-4AF7-A8BD-DB07A515C8D2Q34302834-8F24C414-2E9F-481F-A324-F677B2F5667AQ34330027-CDFA046B-B4E1-4815-8195-FA3C6472C223Q34330033-3C40AF8A-E7D2-48CD-BB61-7FA36FB169BAQ34495620-E164E009-ED02-462F-ACBD-74F5EEB491E6Q34550978-8DF22E93-339B-4F29-B614-9A9526553A5BQ34558918-44565519-3820-40C9-83F8-4C0C3D5C338FQ34581160-65728DC7-D129-481B-8B99-C7A17C47CF93Q34756267-0F35BE34-2AF5-4FED-BD2D-C39D7A643128Q34802793-1C8B46B9-4AE6-4DD6-950A-A2F1921E21A4Q34887528-536784D6-DD79-4216-A5E6-703F2D027C1DQ34971771-CA85DF3F-EC11-46C0-90E4-B03CDB546632Q35048524-BB329A39-556D-4DD7-B5FB-86FA57771854Q35144197-157000DA-0079-46A2-A63A-57DFBFA0A47BQ35176121-EB3127E0-F97B-4FF9-A9A7-D450A80456B9Q35181159-5E494CA7-87CF-4C8F-A952-2F66BC0A17ABQ35231687-46B38551-F7A9-4F69-AC69-A1F8F6D0A1AEQ35291689-68ED3437-B360-4FCE-B2BB-54FB17E42EFAQ35414980-BEA7CCE4-BF53-441F-A9EE-03F2F07B3283Q35608000-A6CCA13A-0C7E-45F4-8F58-0C85A2405A46
P2860
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@ast
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@en
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@nl
type
label
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@ast
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@en
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@nl
prefLabel
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@ast
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@en
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@nl
P2093
P1476
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
@en
P2093
Anna Frolov
David R Rowley
Gustavo Ayala
Jeffrey Spitler
Jennifer A Tuxhorn
Makoto Ohori
Marcus Wheeler
Peter T Scardino
Thomas M Wheeler
P304
P407
P577
2003-10-01T00:00:00Z